Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 4990

1.

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer.

Yamamoto N, Hayashi H, Planchard D, Morán T, Gregorc V, Dowell J, Sakai H, Yoh K, Nishio M, Cortot AB, Benhadji KA, Soni N, Huang J, Makris L, Cedres S.

Invest New Drugs. 2020 Apr 3. doi: 10.1007/s10637-020-00930-5. [Epub ahead of print]

PMID:
32246224
2.

Radiological findings and outcomes of anterior wall fractures in pertrochanteric fractures.

Yamamoto N, Tamura R, Inoue T, Noda T, Nagano H, Ozaki T.

J Orthop Sci. 2020 Mar 30. pii: S0949-2658(20)30072-5. doi: 10.1016/j.jos.2020.02.020. [Epub ahead of print]

PMID:
32241602
3.

BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma.

Watanabe S, Shimomura A, Kubo T, Sekimizu M, Seo T, Watanabe SI, Kawai A, Yamamoto N, Tamura K, Kohno T, Ichikawa H, Yoshida A.

Mod Pathol. 2020 Apr 1. doi: 10.1038/s41379-020-0530-3. [Epub ahead of print]

PMID:
32238877
4.

Cerebral Venous Thrombosis: An Unexpected Complication with Cerebrospinal Fluid Leaks after a Fall in a Patient with Spinocerebellar Ataxia Type 6.

Yamamoto Y, Yamamoto N, Fujita K, Fukumoto T, Murakami N, Mure H, Kanematsu Y, Takagi Y, Izumi Y.

Intern Med. 2020 Apr 2. doi: 10.2169/internalmedicine.4388-20. [Epub ahead of print]

5.

Hypoxia Inducible Factor-1α Inhibition in Von Hippel Lindau-mutant Malignant Pleural Mesothelioma Cells.

Shukuya T, Oyanagi J, Serizawa M, Watanabe M, Yamamoto N, Koh Y.

Anticancer Res. 2020 Apr;40(4):1867-1874. doi: 10.21873/anticanres.14140.

PMID:
32234874
6.

Cilostazol uncovers covert atrial fibrillation in non-cardioembolic stroke.

Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K; ADS investigators.

J Neurol Sci. 2020 Mar 21;413:116796. doi: 10.1016/j.jns.2020.116796. [Epub ahead of print]

PMID:
32222589
7.

Inhibition of PI3Kδ Enhances Poly I:C-Induced Antiviral Responses and Inhibits Replication of Human Metapneumovirus in Murine Lungs and Human Bronchial Epithelial Cells.

Fujita A, Kan-O K, Tonai K, Yamamoto N, Ogawa T, Fukuyama S, Nakanishi Y, Matsumoto K.

Front Immunol. 2020 Mar 11;11:432. doi: 10.3389/fimmu.2020.00432. eCollection 2020.

8.

Atypical ulnar fracture with atypical femoral fracture: A case report and literature review.

Yamamoto N, Yamauchi M, Noda T, Matsui Y, Ozaki T.

J Orthop Sci. 2020 Mar 23. pii: S0949-2658(20)30066-X. doi: 10.1016/j.jos.2020.02.014. [Epub ahead of print] No abstract available.

PMID:
32217052
9.

Expression Pattern of Plexin Domain Containing 2 in Human Hepatocellular Carcinoma.

Yamamoto N, Eguchi A, Hirokawa Y, Ogura S, Sugimoto K, Iwasa M, Watanabe M, Takei Y.

Monoclon Antib Immunodiagn Immunother. 2020 Mar 23. doi: 10.1089/mab.2019.0050. [Epub ahead of print]

PMID:
32202949
10.

Prognostic impact of the presence of on-duty cardiologist on patients with acute myocardial infarction admitted during off-hours.

Marume K, Nagatomo K, Yamamoto N, Kaichi R, Mori T, Komaki S, Ishii M, Kusaka H, Toida R, Kurogi K, Nagamine Y, Takashio S, Arima Y, Sakamoto K, Yamamoto E, Kaikita K, Tsujita K.

J Cardiol. 2020 Mar 18. pii: S0914-5087(20)30072-1. doi: 10.1016/j.jjcc.2020.02.016. [Epub ahead of print]

PMID:
32199752
11.

Pharmacokinetic analysis for model-supported therapeutic drug monitoring of busulfan in Japanese pediatric hematopoietic stem cell transplantation recipients.

Kishimoto K, Hasegawa D, Irie K, Okada A, Nakamura S, Tamura A, Yamamoto N, Kozaki A, Saito A, Ishida T, Fukushima S, Kosaka Y.

Pediatr Transplant. 2020 Mar 20:e13696. doi: 10.1111/petr.13696. [Epub ahead of print]

PMID:
32196880
12.

Clinical characteristics of adrenal insufficiency as an immune-related adverse event in non-small-cell lung cancer.

Ida H, Goto Y, Sato J, Kanda S, Shinno Y, Morita R, Murakami S, Matsumoto Y, Yoshida T, Horinouchi H, Fujiwara Y, Yamamoto N, Fukuda T, Ohashi K, Ohe Y.

Med Oncol. 2020 Mar 16;37(4):30. doi: 10.1007/s12032-020-01357-x.

PMID:
32180046
13.

Research of postpartum endometritis in Japanese Black cattle with cystic ovarian disease by vaginal mucus test and endometrial cytology.

Yamamoto N, Nishimura R, Gunji Y, Hishinuma M.

Arch Anim Breed. 2020 Jan 7;63(1):1-8. doi: 10.5194/aab-63-1-2020. eCollection 2020.

14.

Reference values for the locomotive syndrome risk test quantifying mobility of 8681 adults aged 20-89 years: A cross-sectional nationwide study in Japan.

Yamada K, Ito YM, Akagi M, Chosa E, Fuji T, Hirano K, Ikeda S, Ishibashi H, Ishibashi Y, Ishijima M, Itoi E, Iwasaki N, Izumida R, Kadoya K, Kamimura M, Kanaji A, Kato H, Kishida S, Mashima N, Matsuda S, Matsui Y, Matsunaga T, Miyakoshi N, Mizuta H, Nakamura Y, Nakata K, Omori G, Osuka K, Uchio Y, Ryu K, Sasaki N, Sato K, Senda M, Sudo A, Takahira N, Tsumura H, Yamaguchi S, Yamamoto N, Nakamura K, Takashi Ohe.

J Orthop Sci. 2020 Mar 12. pii: S0949-2658(20)30017-8. doi: 10.1016/j.jos.2020.01.011. [Epub ahead of print]

15.

Airway management strategy for accidental tracheal extubation in the prone position: A simulation study.

Yamamoto N, Ishii A, Miyashita T, Goto T.

J Clin Anesth. 2020 Mar 12;63:109786. doi: 10.1016/j.jclinane.2020.109786. [Epub ahead of print] No abstract available.

PMID:
32172151
16.

Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.

Okamoto I, Nokihara H, Nomura S, Niho S, Sugawara S, Horinouchi H, Azuma K, Yoneshima Y, Murakami H, Hosomi Y, Atagi S, Ozaki T, Horiike A, Fujita Y, Okamoto H, Ando M, Yamamoto N, Ohe Y, Nakagawa K.

JAMA Oncol. 2020 Mar 12:e196828. doi: 10.1001/jamaoncol.2019.6828. [Epub ahead of print]

PMID:
32163097
17.
18.

Safety and efficacy of first-line dacomitinib in Japanese patients with advanced non-small cell lung cancer.

Nishio M, Kato T, Niho S, Yamamoto N, Takahashi T, Nogami N, Kaneda H, Fujita Y, Wilner K, Yoshida M, Isozaki M, Wada S, Tsuji F, Nakagawa K.

Cancer Sci. 2020 Mar 11. doi: 10.1111/cas.14384. [Epub ahead of print]

19.

[A Case of Long-Term Survival after Multidisciplinary Treatment for Gastrointestinal Neuroendocrine Carcinoma].

Yotsumoto H, Yamamoto N, Kamiya M, Inoue H, Washimi K, Okubo Y, Oike N, Yokose T, Rino Y, Masuda M, Morinaga S.

Gan To Kagaku Ryoho. 2019 Dec;46(13):2270-2272. Japanese.

PMID:
32156901
20.

Rare pancreatic metastasis of undifferentiated pleomorphic sarcoma originating from the pelvis: A case report.

Ohsawa M, Mikuriya Y, Ohta K, Tanada M, Yamamoto N, Teramoto N, Kiyono M, Sugihara S.

Int J Surg Case Rep. 2020 Feb 21;68:140-144. doi: 10.1016/j.ijscr.2020.02.041. [Epub ahead of print]

21.

Efficient Prediction of Vitamin B Deficiencies via Machine-Learning Using Routine Blood Test Results in Patients With Intense Psychiatric Episode.

Tamune H, Ukita J, Hamamoto Y, Tanaka H, Narushima K, Yamamoto N.

Front Psychiatry. 2020 Feb 20;10:1029. doi: 10.3389/fpsyt.2019.01029. eCollection 2019.

22.

Intramedullary fixation with bioabsorbable and osteoconductive hydroxyapatite/poly-L-lactide threaded pin in digital replantation.

Yanagibayashi S, Nishijima A, Yoshida R, Sasaki K, Yamamoto N, Takikawa M.

J Plast Surg Hand Surg. 2020 Mar 10:1-5. doi: 10.1080/2000656X.2020.1738239. [Epub ahead of print]

PMID:
32153234
23.

Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer.

Shibaki R, Murakami S, Shinno Y, Matsumoto Y, Yoshida T, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Yamamoto N, Ohe Y.

Cancer Immunol Immunother. 2020 Mar 10. doi: 10.1007/s00262-020-02539-2. [Epub ahead of print]

PMID:
32152703
24.

Retrospective analysis of high-dose chemotherapy followed by autologous stem cell transplantation for high-risk pediatric osteosarcoma.

Uemura S, Mori T, Ishiko S, Takafuji S, Nino N, Yamamoto N, Hayakawa A, Nishimura N, Hara H, Kawamoto T, Akisue T, Iijima K.

Pediatr Hematol Oncol. 2020 Mar 10:1-7. doi: 10.1080/08880018.2020.1729906. [Epub ahead of print]

PMID:
32151185
25.

Risk factors of infectious complications after endobronchial ultrasound-guided transbronchial biopsy.

Souma T, Minezawa T, Yatsuya H, Okamura T, Yamatsuta K, Morikawa S, Horiguchi T, Maeda S, Goto Y, Hayashi M, Isogai S, Yamamoto N, Kondo M, Imaizumi K.

Chest. 2020 Mar 4. pii: S0012-3692(20)30346-9. doi: 10.1016/j.chest.2020.02.025. [Epub ahead of print]

26.

Letter to the editor concerning "Li P., lv Y., zhou F., et al. medial wall fragment involving large posterior cortex in Pertrochanteric femur fractures: A notable preoperative risk factor for implant failure. injury. 2020".

Yamamoto N, Noda T, Ozaki T.

Injury. 2020 Feb 20. pii: S0020-1383(20)30153-4. doi: 10.1016/j.injury.2020.02.078. [Epub ahead of print] No abstract available.

PMID:
32143856
27.

Impact of Postoperative Complications on Recurrence in Patients With Stage II/III Gastric Cancer Who Received Adjuvant Chemotherapy With S-1.

Watanabe H, Hayashi T, Komori K, Hara K, Maezawa Y, Kano K, Shimoda Y, Fujikawa H, Aoyama T, Yamada T, Yamamoto N, Cho H, Ito H, Shiozawa M, Yukawa N, Morinaga S, Yoshikawa T, Rino Y, Masuda M, Ogata T, Oshima T.

Anticancer Res. 2020 Mar;40(3):1683-1690. doi: 10.21873/anticanres.14120.

PMID:
32132075
28.

Structure-Activity Relationship between Thiol Group-Trapping Ability of Morphinan Compounds with a Michael Acceptor and Anti-Plasmodium falciparum Activities.

Kutsumura N, Koyama Y, Saitoh T, Yamamoto N, Nagumo Y, Miyata Y, Hokari R, Ishiyama A, Iwatsuki M, Otoguro K, Ōmura S, Nagase H.

Molecules. 2020 Mar 2;25(5). pii: E1112. doi: 10.3390/molecules25051112.

29.

Correlation between folate receptor alpha (FRα) expression and clinicopathological features in lung adenocarcinoma.

Tamura N, Fujiwara Y, Hashimoto T, Shiraishi H, Kitano S, Shimizu T, Yamamoto N, Motoi N.

Ann Oncol. 2019 Apr;30 Suppl 2:ii2. doi: 10.1093/annonc/mdz072.003. No abstract available.

30.

Clonal Hematopoiesis From Next Generation Sequencing of Plasma From a Patient With Lung Adenocarcinoma: A Case Report.

Ito M, Fujiwara Y, Kubo T, Matsushita H, Kumamoto T, Suzuki T, Sunami K, Yamamoto N, Kohno T.

Front Oncol. 2020 Feb 13;10:113. doi: 10.3389/fonc.2020.00113. eCollection 2020.

31.

MASTER KEY Project: Powering Clinical Development for Rare Cancers through a Platform Trial.

Okuma HS, Yonemori K, Narita SN, Sukigara T, Hirakawa A, Shimizu T, Shibata T, Kawai A, Yamamoto N, Nakamura K, Nishida T, Fujiwara Y.

Clin Pharmacol Ther. 2020 Feb 29. doi: 10.1002/cpt.1817. [Epub ahead of print]

PMID:
32112563
32.

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus.

Matsunaga S, Jeremiah SS, Miyakawa K, Kurotaki D, Shizukuishi S, Watashi K, Nishitsuji H, Kimura H, Tamura T, Yamamoto N, Shimotohno K, Wakita T, Ryo A.

iScience. 2020 Mar 27;23(3):100867. doi: 10.1016/j.isci.2020.100867. Epub 2020 Feb 26.

33.

Clinical Profiles of DFNA11 at Diverse Stages of Development and Aging in a Large Family Identified by Linkage Analysis.

Yamamoto N, Mutai H, Namba K, Goto F, Ogawa K, Matsunaga T.

Otol Neurotol. 2020 Feb 25. doi: 10.1097/MAO.0000000000002604. [Epub ahead of print]

PMID:
32097363
34.

Field localization of hexagonal and short-range ordered plasmonic nanoholes investigated by cathodoluminescence.

Vu Thi D, Ohno T, Yamamoto N, Sannomiya T.

J Chem Phys. 2020 Feb 21;152(7):074707. doi: 10.1063/1.5131698.

PMID:
32087626
35.

Dynamic change in the distribution of cancer types in oncology phase I trials.

Sato J, Itahashi K, Shimizu T, Koyama T, Kondo S, Fujiwara Y, Yamamoto N.

Ann Oncol. 2019 Feb;30 Suppl 1:i12. doi: 10.1093/annonc/mdz026.001. Epub 2020 Jan 8. No abstract available.

36.

Number of metastatic organs negatively affects the treatment sequence in patients with EGFR-TKI failure.

Mizuno T, Horinouchi H, Watanabe S, Sato J, Morita R, Murakami S, Goto Y, Kanda S, Fujiwara Y, Yamamoto N, Ohe Y.

Thorac Cancer. 2020 Apr;11(4):1038-1044. doi: 10.1111/1759-7714.13360. Epub 2020 Feb 20.

37.

VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration.

Yamamoto N, Oyaizu T, Enomoto M, Horie M, Yuasa M, Okawa A, Yagishita K.

Sci Rep. 2020 Feb 17;10(1):2744. doi: 10.1038/s41598-020-59615-x.

38.

Propensity score-weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non-small cell lung cancer (WJOG10217L).

Kato R, Hayashi H, Chiba Y, Miyawaki E, Shimizu J, Ozaki T, Fujimoto D, Toyozawa R, Nakamura A, Kozuki T, Tanaka K, Teraoka S, Usui K, Nishino K, Hataji O, Ota K, Ebi N, Saeki S, Akazawa Y, Okuno M, Yamamoto N, Nakagawa K.

J Immunother Cancer. 2020 Feb;8(1). pii: e000350. doi: 10.1136/jitc-2019-000350.

39.

Polypoid gallbladder neuroendocrine tumor diagnosed as benign polyp before surgery: A case report.

Naito S, Naito M, Yamamoto N, Kume T, Hosino S, Kinjyo Y, Naito Y, Naito H, Hasegawa S.

Mol Clin Oncol. 2020 Mar;12(3):225-229. doi: 10.3892/mco.2019.1971. Epub 2019 Dec 24.

40.

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.

Yamashiro H, Iwata H, Masuda N, Yamamoto N, Nishimura R, Ohtani S, Sato N, Takahashi M, Kamio T, Yamazaki K, Saito T, Kato M, Lee T, Kuroi K, Takano T, Yasuno S, Morita S, Ohno S, Toi M; JBCRG-C01 Collaborative Group.

Breast Cancer. 2020 Feb 14. doi: 10.1007/s12282-020-01057-4. [Epub ahead of print]

PMID:
32060785
41.

Imaging-guided PCI for event suppression in Japanese acute coronary syndrome patients: community-based observational cohort registry.

Yamashita T, Sakamoto K, Tabata N, Ishii M, Sato R, Nagamatsu S, Motozato K, Yamanaga K, Sueta D, Araki S, Arima Y, Yamamoto E, Takashio S, Fujisue K, Fujimoto K, Shimomura H, Tsunoda R, Maruyama H, Nakamura N, Sakaino N, Nakamura S, Yamamoto N, Matsumura T, Kajiwara I, Tayama S, Sakamoto T, Nakao K, Oshima S, Kaikita K, Hokimoto S, Tsujita K; Kumamoto Intervention Conference Study (KICS) Investigators.

Cardiovasc Interv Ther. 2020 Feb 12. doi: 10.1007/s12928-020-00649-3. [Epub ahead of print]

PMID:
32052349
42.

Desloratadine inhibits heterotopic ossification by suppression of BMP2-Smad1/5/8 signaling.

Kusano T, Nakatani M, Ishiguro N, Ohno K, Yamamoto N, Morita M, Yamada H, Uezumi A, Tsuchida K.

J Orthop Res. 2020 Feb 11. doi: 10.1002/jor.24625. [Epub ahead of print]

PMID:
32043642
43.

Effect of transcatheter arterial embolisation in normal canine liver using trisacryl gelatine microspheres (Embosphere).

Nakasumi K, Sunahara H, Igari K, Itoh H, Itamoto K, Yamamoto N, Ishikawa T, Takami T, Sakaida I, Taura Y, Tani K.

Res Vet Sci. 2020 Apr;129:174-177. doi: 10.1016/j.rvsc.2020.01.018. Epub 2020 Jan 23.

PMID:
32036125
44.

The Intravitreal Injection of Lanosterol Nanoparticles Rescues Lens Structure Collapse at an Early Stage in Shumiya Cataract Rats.

Nagai N, Fukuoka Y, Sato K, Otake H, Taga A, Oka M, Hiramatsu N, Yamamoto N.

Int J Mol Sci. 2020 Feb 5;21(3). pii: E1048. doi: 10.3390/ijms21031048.

45.

Pedicle frozen autograft-prosthesis composite reconstructions for malignant bone tumors of the proximal femur.

Xu G, Miwa S, Yamamoto N, Hayashi K, Takeuchi A, Igarashi K, Higuchi T, Taniguchi Y, Araki Y, Yonezawa H, Morinaga S, Tsuchiya H.

BMC Musculoskelet Disord. 2020 Feb 6;21(1):81. doi: 10.1186/s12891-020-3112-0.

46.

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy.

Tokudome N, Koh Y, Akamatsu H, Fujimoto D, Okamoto I, Nakagawa K, Hida T, Imamura F, Morita S, Yamamoto N.

BMC Cancer. 2020 Feb 6;20(1):103. doi: 10.1186/s12885-020-6593-1.

47.

Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.

Takahama T, Azuma K, Shimokawa M, Takeda M, Ishii H, Kato T, Saito H, Daga H, Tsuboguchi Y, Okamoto I, Otsubo K, Akamatsu H, Teraoka S, Takahashi T, Ono A, Ohira T, Yokoyama T, Sakai K, Yamamoto N, Nishio K, Nakagawa K.

Cancer. 2020 Feb 5. doi: 10.1002/cncr.32749. [Epub ahead of print]

PMID:
32022929
48.

Oral intake of α‑glucosyl‑hesperidin ameliorates selenite‑induced cataract formation.

Nakazawa Y, Aoki M, Ishiwa S, Morishita N, Endo S, Nagai N, Yamamoto N, Funakoshi-Tago M, Tamura H.

Mol Med Rep. 2020 Mar;21(3):1258-1266. doi: 10.3892/mmr.2020.10941. Epub 2020 Jan 14.

49.

Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system.

Ikeda M, Koh Y, Teraoka S, Sato K, Kanai K, Hayata A, Tokudome N, Akamatsu H, Ozawa Y, Akamatsu K, Endo K, Higuchi M, Nakanishi M, Ueda H, Yamamoto N.

Cancer Med. 2020 Mar;9(6):2122-2133. doi: 10.1002/cam4.2846. Epub 2020 Jan 30.

50.

Difficult-To-Detect Staphylococcus aureus: mecA-Positive Isolates Associated with Oxacillin and Cefoxitin False-Susceptible Results.

Gargis AS, Yoo BB, Lonsway DR, Anderson K, Campbell D, Ewing TO, Lawsin A, Machado MJ, Yamamoto N, Halpin AL, Lutgring JD, Karlsson M, Rasheed JK, Elkins CA.

J Clin Microbiol. 2020 Mar 25;58(4). pii: e02038-19. doi: 10.1128/JCM.02038-19. Print 2020 Mar 25. No abstract available.

PMID:
31996449

Supplemental Content

Loading ...
Support Center